3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionall...

Full description

Saved in:
Bibliographic Details
Main Authors LEVELEKI CSILLA, FLORIAN ENDRENE, KAPILLERNE DEZSOFI RITA, GACSALYI ISTVAN, VOLK BALAZS, MEZEI TIBOR, SZENASI GABOR, EGYED ANDRAS, SZIRAY NORA, MORICZ KRISZTINA, BARKOCZY JOZSEF, PALLAGI KATALIN, GIGLER GABOR, LEVAY GYORGY, SIMIG GYULA, HARSING LASZLO GABOR
Format Patent
LanguageEnglish
Slovenian
Published 31.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.
AbstractList The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R2 represents hydrogen or halogen; R3 denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R4 stands for alkyl having 1-7 carbon atom(s); R5 represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R6, R7 and R8 each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R6 and R7 together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.
Author KAPILLERNE DEZSOFI RITA
MORICZ KRISZTINA
EGYED ANDRAS
GIGLER GABOR
LEVAY GYORGY
SIMIG GYULA
FLORIAN ENDRENE
GACSALYI ISTVAN
SZENASI GABOR
BARKOCZY JOZSEF
MEZEI TIBOR
VOLK BALAZS
PALLAGI KATALIN
LEVELEKI CSILLA
HARSING LASZLO GABOR
SZIRAY NORA
Author_xml – fullname: LEVELEKI CSILLA
– fullname: FLORIAN ENDRENE
– fullname: KAPILLERNE DEZSOFI RITA
– fullname: GACSALYI ISTVAN
– fullname: VOLK BALAZS
– fullname: MEZEI TIBOR
– fullname: SZENASI GABOR
– fullname: EGYED ANDRAS
– fullname: SZIRAY NORA
– fullname: MORICZ KRISZTINA
– fullname: BARKOCZY JOZSEF
– fullname: PALLAGI KATALIN
– fullname: GIGLER GABOR
– fullname: LEVAY GYORGY
– fullname: SIMIG GYULA
– fullname: HARSING LASZLO GABOR
BookMark eNqNzE1qwzAQBWAv2kX_7jDZudBZOCoNXQprjERljRlNDO4mhKCsghNID9SjNqE9QFffe_B499XNfJzLXfVtsK7rVxw8pSk-4xAGEvsZEjZ47TZ-XDG_AZsXgy74yQnj0mNIjiMukROBIwmj1TBSBpscCEWr5KDlfuB1chk6FlBPoEJWe0oK3EF7UWyERDLyOkOeslIPLmSWy2V-rG7328O5PP35UC060tZjOR035Xza7spcvjY5NKvVmzHvqo35z-YHC1ZGAQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Derivati 3-(((4-fenil)-piperazin-1-il)-alkil)-3-alkil-1,3-dihidro-2H-indol-2-ona in sorodne spojine za zdravljenje motenj centralnega živčnega sistema
ExternalDocumentID SI1776339TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_SI1776339TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Slovenian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SI1776339TT13
Notes Application Number: SI20050030785T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091231&DB=EPODOC&CC=SI&NR=1776339T1
ParticipantIDs epo_espacenet_SI1776339TT1
PublicationCentury 2000
PublicationDate 20091231
PublicationDateYYYYMMDD 2009-12-31
PublicationDate_xml – month: 12
  year: 2009
  text: 20091231
  day: 31
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies EGIS GYOGYSZERGYAR NYRT
RelatedCompanies_xml – name: EGIS GYOGYSZERGYAR NYRT
Score 2.7566626
Snippet The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R1 stands for hydrogen, halogen,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title 3-(((4-PHENYL)-PIPERAZIN-1-YL)-ALKYL)-3-ALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091231&DB=EPODOC&locale=&CC=SI&NR=1776339T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA5jivrmFZ0XIsiYYHC9rdtDka7JaHVLSpONzZfRrR0MZBtu4t_xp3paN_VFn3KSQCAJ3znny-UchG7ASMT1iZWSpFpLiDmyLBKDG080OzYmdmKm1Tw3YIfX_K752Lf6BTTd_IXJ44S-58ERAVFjwPsq19eLn0Msmr-tXN6PptA0f2gph5Y37LgBilgr06bDQkGFV_Y8RwZlHjmaDUAyGgqI0hZ40XYGBtZrZp9SFr8tSmsfbYcw2Gx1gArLl0O0620Srx2inc76vhvENfSWR-jDIJVKxSShz_igfUvCIGSR-xxwYGdZ3W0_ZYXxJRDtziA08Ac0EkT3ScCpaBOdCM4wBe7Wc1XQYxK7nOIsawboL-yJTii6nEoMzBArn2EVMVdl0f6xaGEPyshtY86inuhKLAdSsQ6mgQQeySJ5jK5bTHk-gakOv5d1KIPNoijNOEHF2XyWniJsJzVdt2sTS0vHWTyw-tgeJQ1Tj4FZJOPEOEOlv8cp_dd5jvb0dfYFQ7tAxdXrW3oJJn01uso34xPROJjb
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA4yxfnmFZ23CDImGFxvq3sYUpuMRtukNNnYfBnb2oEgU9zEv-NP9bRu6os-5SSBQBK-c86XyzkInYORGF5PnIyk9UZK7JHjkCG48cRwh9bETe2sXuQGjEQj6Nh3Pae3gh6Xf2GKOKHvRXBEQNQY8D4v9PXLzyEWLd5Wzq5Gj9D0fNPWLVpdsuMmKGKjSm9bLJZU-lXfbyleFUnLcAFIVlMDUVoFD9vNwcC6t_mnlJffFqW9idZiGGw630Irs6dtVPaXide20Xq0uO8GcQG92Q76sEitVrNJHDDRDy9IzGOWeA9cADvL6154nxfWl0CMS4tQHvRpIokZEC6oDIlJpGCYAnfrepp3mcKeoDjPmgH6C_syimVHUIWBGWIdMKwT5uk82j-WbexDmXghFizpyo7Cqq80izDlCngkS9QuOmsz7QcEpjr4XtaB4stF0Ya1h0rT52m2j7CbNkzTbUwcIxvn8cCux-4obdrmEJhFOk6tA1T5e5zKf52nqBzoKByEXNwfog1zkYnBMo5Qaf76lh2DeZ-PToqN-QQrX5vO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-%28%28%284-PHENYL%29-PIPERAZIN-1-YL%29-ALKYL%29-3-ALKYL-1%2C3-DIHYDRO-2H-INDOL-2-ONE+DERIVATIVES+AND+RELATED+COMPOUNDS+FOR+THE+TREATMENT+OF+CENTRAL+NERVOUS+SYSTEM+DISORDERS&rft.inventor=LEVELEKI+CSILLA&rft.inventor=FLORIAN+ENDRENE&rft.inventor=KAPILLERNE+DEZSOFI+RITA&rft.inventor=GACSALYI+ISTVAN&rft.inventor=VOLK+BALAZS&rft.inventor=MEZEI+TIBOR&rft.inventor=SZENASI+GABOR&rft.inventor=EGYED+ANDRAS&rft.inventor=SZIRAY+NORA&rft.inventor=MORICZ+KRISZTINA&rft.inventor=BARKOCZY+JOZSEF&rft.inventor=PALLAGI+KATALIN&rft.inventor=GIGLER+GABOR&rft.inventor=LEVAY+GYORGY&rft.inventor=SIMIG+GYULA&rft.inventor=HARSING+LASZLO+GABOR&rft.date=2009-12-31&rft.externalDBID=T1&rft.externalDocID=SI1776339TT1